Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CD PRIVATE EQUITY FUND I Interim / Quarterly Report 2022

Oct 13, 2022

64626_rns_2022-10-13_7331e31b-5046-4167-b3e5-c28098f7eac6.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

Monthly update – September 2022

CD Private Equity Fund I

==> picture [457 x 52] intentionally omitted <==

----- Start of picture text ----- NTA Gross assets Distributions per unit One month Annualised performance sinceper unit (millions) (percentage of initial investment) performance [1,2] inception (August 2012) [1,2]Last 12 months: Since inception: 244$1.52 $56.80 23.5 cents (15%) cents (153%) 7.0% 14.7%----- End of picture text -----

Fund update

The estimated unaudited net tangible asset value (NTA) after tax as at 30 September 2022 was $1.52[1,3] per unit (31 August 2022 was $1.42[1] per unit).

Net asset value movements for September were primarily a result of foreign exchange gains due to the depreciating Australian dollar (which added approximately 6.9%).

CD1 Fund performance

==> picture [456 x 39] intentionally omitted <==

----- Start of picture text ----- 1 Month 3 Months 6 Months 1 Year 3 Years p.a. 5 Years p.a. Since inception p.a. [3]NTA return [1,2] 7.0% 4.8% 16.0% 14.5% 17.7% 20.9% 14.7%----- End of picture text -----

On an NTA/Internal Rate of Return (IRR) basis CD1 has achieved a return of 12.9% per annum since inception.

CD1 portfolio asset allocation

==> picture [198 x 22] intentionally omitted <==

----- Start of picture text ----- LP commitments to underlying managers(US$69.8m)----- End of picture text -----

==> picture [439 x 172] intentionally omitted <==

----- Start of picture text ----- Distribution DFW*Software & Business EncoreTechnology 9.4% Services $5.0$10.04.0% US Select24.3% FPCHealthcare Direct10.8% $13.0 $4.0$10.0 Incline10.8%Manufacturing $10.0Trivest4.6%36.2% $4.8 $10.0Telecommunications $3.0KarpReillyConsumer & Retail Prometheus*Peppertree----- End of picture text -----

cdfunds.com.au ARSN 158 625 284

T 1300 454 801 F 1300 883 159 E [email protected]